Follow
Christopher Sweeney
Christopher Sweeney
Verified email at adelaide.edu.au
Title
Cited by
Cited by
Year
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer
CJ Sweeney, YH Chen, M Carducci, G Liu, DF Jarrard, M Eisenberger, ...
New England Journal of Medicine 373 (8), 737-746, 2015
29282015
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
12652019
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ...
Science translational medicine 4 (128), 128ra39-128ra39, 2012
12102012
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial
CE Kyriakopoulos, YH Chen, MA Carducci, G Liu, DF Jarrard, NM Hahn, ...
Journal of Clinical Oncology 36 (11), 1080-1087, 2018
9862018
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
859*2018
Redefining the target: chemotherapeutics as antiangiogenics
KD Miller, CJ Sweeney, GW Sledge Jr
Journal of clinical oncology 19 (4), 1195-1206, 2001
5432001
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
DC Smith, MR Smith, C Sweeney, AA Elfiky, C Logothetis, PG Corn, ...
Journal of clinical oncology 31 (4), 412-419, 2013
5202013
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
ML Guzman, RM Rossi, S Neelakantan, X Li, CA Corbett, DC Hassane, ...
Blood, The Journal of the American Society of Hematology 110 (13), 4427-4435, 2007
5152007
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
F Meric-Bernstam, H Hurwitz, KPS Raghav, RR McWilliams, M Fakih, ...
The Lancet Oncology 20 (4), 518-530, 2019
5082019
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of …
CL Vale, S Burdett, LHM Rydzewska, L Albiges, NW Clarke, D Fisher, ...
The lancet oncology 17 (2), 243-256, 2016
4882016
Targeted therapy for advanced solid tumors on the basis of molecular profiles: results from MyPathway, an open-label, phase IIa multiple basket study
JD Hainsworth, F Meric-Bernstam, C Swanton, H Hurwitz, DR Spigel, ...
Journal of Clinical Oncology 36 (6), 536-542, 2018
4492018
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but …
CJ Sweeney, KD Miller, SE Sissons, S Nozaki, DK Heilman, J Shen, ...
Cancer research 61 (8), 3369-3372, 2001
4262001
Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer
W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ...
Journal of Clinical Oncology 35 (27), 3097-3104, 2017
4082017
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation
CL Hsieh, T Fei, Y Chen, T Li, Y Gao, X Wang, T Sun, CJ Sweeney, ...
Proceedings of the National Academy of Sciences 111 (20), 7319-7324, 2014
4032014
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
3802015
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
MT Yip-Schneider, DS Barnard, SD Billings, L Cheng, DK Heilman, A Lin, ...
Carcinogenesis 21 (2), 139-146, 2000
3752000
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
A Pettersson, RE Graff, SR Bauer, MJ Pitt, RT Lis, EC Stack, NE Martin, ...
Cancer epidemiology, biomarkers & prevention 21 (9), 1497-1509, 2012
3582012
Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis
JH Hayes, DA Ollendorf, SD Pearson, MJ Barry, PW Kantoff, ST Stewart, ...
Jama 304 (21), 2373-2380, 2010
3362010
The burden of chronic spontaneous urticaria is substantial: real‐world evidence from ASSURE‐CSU
M Maurer, M Abuzakouk, F Bérard, W Canonica, H Oude Elberink, ...
Allergy 72 (12), 2005-2016, 2017
3212017
Outcome of patients with a performance status of 2 in eastern cooperative oncology group study E1594: a phase III trial in patients with metastatic nonsmall cell lung carcinoma
CJ Sweeney, J Zhu, AB Sandler, J Schiller, CP Belani, C Langer, J Krook, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2001
3102001
The system can't perform the operation now. Try again later.
Articles 1–20